In this episode of In Her Code, host Veronika Posch sits down with Ida Tin, founder of Clue and the woman who coined the term FemTech, to explore what it will actually take to move women's health from reactive care to preventive infrastructure. Ida makes the case that the real gap is not awareness, it's data. Without continuous hormonal monitoring, women's health remains episodic by design, leading to delayed diagnoses and solutions built on incomplete pictures.
The conversation spans the economics of conviction capital, the strategic power of language in shaping entire industries, and why reframing women's health as universal health is not just a narrative shift but a structural one. They also dive into the ethics of health data, the role of grassroots communities in driving innovation, and why AI in women's health is only as good as the data it's trained on.
Ida also introduces the Sprind Continuous Hormone Monitoring Challenge, backed by €40 million in funding and focused on advancing innovation in the field of hormonal health. A strong example of how conviction capital, when it shows up at scale, can move an entire field forward.
If women's health is going to scale, it won't happen through isolated products. It requires better infrastructure, cross-gender engagement, and investors willing to follow founders beyond the early stage.
Apply now: Sprind Challenge Website
Connect with Ida Tin on LinkedIn
#WomensHealth #SprindChallenge #Femtech #Startups # Business #Innovation #HealthTech #InHerCode #AI
","author_name":"Veronika-Adriane Posch"}